← BMJ Neurology Open

Papers in BMJ Neurology Open

Page 1 · newest first

1. Stroke reperfusion in Aotearoa New Zealand: 5-year trends and a comparison of stroke clot retrieval and non-stroke clot retrieval centre presentersBMJ Neurology Open · 2026
2. Recruitment strategies in a diverse Parkinson’s disease cohort: lessons from the East London Parkinson’s Disease ProjectBMJ Neurology Open · 2026
3. Executive functions and cognitive disengagement syndrome as predictors of suicidal behaviour: the mediating role of psychotic-like experiencesBMJ Neurology Open · 2026
4. Stroke and its consequences: protocol and pilot data of the observational Berlin Long-term Observation of Vascular Events (BeLOVE) stroke stratumBMJ Neurology Open · 2026
5. Identifying and predicting fast versus slow Parkinson’s disease motor progressors using clinical and digital dataBMJ Neurology Open · 2026
6. Association of coronary artery bypass with cognitive impairment in coronary artery disease across APO (ε) genotypes in AllofUSBMJ Neurology Open · 2026
7. Inpatient versus outpatient management of bilateral optic nerve head elevation presentation to a tertiary emergency departmentBMJ Neurology Open · 2026
8. Leucocytosis and outcomes in older ICU patients after ischaemic stroke: a binational multicentre cohort studyBMJ Neurology Open · 2026
9. Association between acute-phase glycaemic metrics and stroke-associated pneumonia in patients with acute ischaemic strokeBMJ Neurology Open · 2026
10. Non-invasive brain stimulation for enhancing dual-task performance in individuals with chronic poststroke hemiparesis: protocol for systematic review and meta-analysisBMJ Neurology Open · 2026
11. Advances in cerebrovascular reserve function assessment for moyamoya diseaseBMJ Neurology Open · 2026
12. Clinicians’ decisions about antibiotic treatment in advanced dementia: an international surveyBMJ Neurology Open · 2026
13. Neurological complications induced by checkpoint inhibitors: characterising the clinical spectraBMJ Neurology Open · 2026
14. Effectiveness of escalation versus early high-efficacy therapies on progression independent of relapse activity in multiple sclerosis: a Danish nationwide studyBMJ Neurology Open · 2026
15. Bridging the gap between guidelines and practice: neurologists’ readiness for the updated McDonald criteria in EgyptBMJ Neurology Open · 2026
16. Comparison of double-blind and open-label decline rates in lecanemab and donanemab trials in Alzheimer’s diseaseBMJ Neurology Open · 2026
17. Refractory epilepsy from lead poisoningBMJ Neurology Open · 2026
18. Long-term functional outcomes and caregiver burden in survivors after decompressive hemicraniectomy for malignant hemispheric infarction: a real-world experience from South IndiaBMJ Neurology Open · 2026
19. Rising burden of Alzheimer’s disease and other dementias in Sierra Leone, 1990–2023: analysis of Global Burden of Disease 2023 estimatesBMJ Neurology Open · 2026
20. Complementary biomarkers or conflicting signals? DaT SPECT and synuclein skin biopsy in parkinsonian syndromesBMJ Neurology Open · 2026
21. Smoking and the risk of neurodegenerative diseases in a Chinese case–control studyBMJ Neurology Open · 2026
22. Enhancing the cognitive, psychological, and social outcomes of adults undergoing surgery for focal drug-resistant epilepsy: protocol for a scoping reviewBMJ Neurology Open · 2026
23. Stroke systems of care: evaluating disparities after stroke legislation implementation in Rhode IslandBMJ Neurology Open · 2026
24. Australian Paediatric Acute Code Stroke study: study protocol for a quasi-experimental trial measuring the impact of Code Stroke protocols on time to diagnosis and access to reperfusion therapiesBMJ Neurology Open · 2026
25. From brain to heart: a single-centre study of ictal and post-ictal asystole in epilepsyBMJ Neurology Open · 2026
26. Deep brain stimulation battery longevity: a cohort study comparing impact of anaesthesia modality and anatomic targetBMJ Neurology Open · 2026
27. Novel predictors of postoperative delirium after awake subthalamic nucleus deep brain stimulation for Parkinson’s diseaseBMJ Neurology Open · 2026
28. Factors influencing functional recovery in posterior circulation stroke following mechanical thrombectomy: a systematic review and meta-analysisBMJ Neurology Open · 2026
29. Efficacy and safety of cipaglucosidase alfa plus miglustat in Japanese adults with late-onset Pompe disease: a case series from clinical trialsBMJ Neurology Open · 2026
30. Disability burden, treatment gaps and correlates of self-reported physician-diagnosed migraine: a multinational survey in four Arab countriesBMJ Neurology Open · 2026
31. AI-driven European Retrospective Database Study to predict disease onset in patients with epilepsy and depressionBMJ Neurology Open · 2026
32. Effects of vibration stimulation on truncal lateropulsion in patients with lateral medullary syndromeBMJ Neurology Open · 2026
33. Impact of white matter hyperintensities on cognitive, motor and functional recovery in veterans following acute/subacute stroke: a prospective studyBMJ Neurology Open · 2026
34. F-minimum latency, F-maximum latency and F-estimate as early markers of neuropathy in type 2 diabetes mellitus: a cross-sectional studyBMJ Neurology Open · 2026
35. Considering prediagnostic environmental modifiers of progression in amyotrophic lateral sclerosisBMJ Neurology Open · 2026
36. Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson’s disease: insights from the French National Healthcare Data System (2015–2021)BMJ Neurology Open · 2026
37. Slowing the curve: a single-arm meta-analysis of mFARS outcomes following omaveloxolone treatment in Friedreich ataxiaBMJ Neurology Open · 2026
38. Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agentsBMJ Neurology Open · 2026
39. 6-minute walk test and the 3-metre backward walk test are sensitive to postoperative gait improvement in idiopathic normal pressure hydrocephalusBMJ Neurology Open · 2026
40. Health inequalities in outpatient neurological conditions across a large UK urban population: a retrospective observational study using automated codingBMJ Neurology Open · 2026
41. Correlation of cerebrospinal fluid IL-6 as a marker of disease activity in patients with longitudinally extensive transverse myelitisBMJ Neurology Open · 2026
42. Efficacy of nebulised dexmedetomidine versus aminophylline for treatment of postdural puncture headache in patients undergoing subarachnoid block posted for caesarean section: a double-blind, randomised controlled studyBMJ Neurology Open · 2026
43. Amyloid-β-related angiitis presenting as leptomeningitisBMJ Neurology Open · 2026
44. Large language models to infer depression in patients with neurological conditionsBMJ Neurology Open · 2026
45. Deep brain stimulation for the treatment of paediatric dystonia due to neuroanatomical abnormalities: a systematic review of efficacy and future perspectivesBMJ Neurology Open · 2026
46. Blood pressure variation and futile recanalisation in patients with large-vessel occlusion after endovascular therapyBMJ Neurology Open · 2026
47. CHI3L1 (YKL-40) and Chit-1 expressing glia in the white matter of ALS, FTLD and AD: correlations to pathology and disease durationBMJ Neurology Open · 2026
48. Arabic version of the General Sleep Disturbance Scale among healthcare night-shift workers: a cross-sectional validation studyBMJ Neurology Open · 2026
49. Foreign body-type giant cell reaction post intracranial endovascular clot retrieval: a postmortem caseBMJ Neurology Open · 2026
50. MOGAD optic neuritis post enterovirus meningitis: a new associationBMJ Neurology Open · 2026